The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Main Authors: | Catucci, Irene, Radice, Paolo, Milne, Roger L., Couch, Fergus J., Southey, Melissa C., Peterlongo, Paolo |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101669/ |
Similar Items
-
Genotype-phenotype correlations of TGFBI p.Leu509Pro, p.Leu509Arg, p.Val613Gly, and the allelic association of p.Met502Val-p.Arg555Gln mutations
by: Niel-Butschi, Florence, et al.
Published: (2011) -
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients
by: Parisi, Giuseppe Fabio, et al.
Published: (2013) -
PALB2 and breast cancer: ready for clinical translation!
by: Southey, Melissa C, et al.
Published: (2013) -
PALB2: research reaching to clinical outcomes for women with breast cancer
by: Southey, Melissa C., et al.
Published: (2016) -
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
by: Teo, Zhi L, et al.
Published: (2013)